It also reduces melanin production, contributing to skin-lightening effects
Asia-Pacific dominates the market (55% share), with Korea and China as production hubs, while North America and Europe show the fastest growth rates due to premiumization
Oral administration follows a ramping protocol: 250 micrograms daily for the first three weeks, increasing to 500 micrograms for maintenance
Whether oral peptides can actually deliver the benefits that injectable protocols provide
it cannot establish superiority, because differences in population, comparator, endpoint, dose, and trial length confound any direct read
Regular monitoring during treatment helps identify any potential issues early